PEN vs QGEN
Penumbra, Inc. vs Qiagen N.V. — AI-powered side-by-side comparison
PEN
Penumbra, Inc.
67
Buy
VS
| Metric | PEN | QGEN |
|---|
| AI Score |
67
|
64
|
| Price |
$326.07
|
$42.66
|
| P/E Ratio |
79.78×
|
21.87×
|
| ROE |
12.4%
|
11.2%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
67.8%
|
61.7%
|
| Debt / Equity |
0.14×
|
0.49×
|
| Dividend Yield |
0.0%
|
6.2%
|
| RSI (14) |
79.6
|
57.5
|
| Beta |
0.701
|
0.62
|
| Expected Upside |
+6.3%
|
—
|
AI Committee View
Current Innellis committee reasoning for PEN versus QGEN.
PEN leads by 3 points.
PEN scores 67/100 (Buy) versus QGEN at 64/100 (Buy).
PEN Committee View
80% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is 2 consecutive earnings misses -- execution concerns. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- 2 consecutive earnings misses -- execution concerns — Growth
- RSI at 80 is in overbought territory — Technical
QGEN Committee View
80% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- EPS growing 341.4% YoY — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro